Can a 'Smart' antibody stop colon Cancer's return?
NCT ID NCT00002968
Summary
This large study tested whether adding a special antibody drug after colon cancer surgery could help patients live longer without their cancer returning. Over 2,100 patients who had surgery for stage II colon cancer were randomly assigned to either receive the antibody treatment or just be observed. The goal was to see if the antibody, which targets cancer cells, could improve survival and prevent recurrence better than surgery alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCINOUS ADENOCARCINOMA OF THE COLON are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer and Leukemia Group B
Chicago, Illinois, 60606, United States
Conditions
Explore the condition pages connected to this study.